Molecular alterations in the TCR signaling pathway in patients with aplastic anemia.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27036622)

Published in J Hematol Oncol on March 31, 2016

Authors

Bo Li1, Lixing Guo2, Yuping Zhang3, Yankai Xiao4, Mingjuan Wu2,4, Lingling Zhou4, Shaohua Chen2, Lijian Yang2, Xiang Lu5, Yangqiu Li6,7,8

Author Affiliations

1: Institute of Hematology, Medical College, Jinan University, Guangzhou, China. libo517@jnu.edu.cn.
2: Institute of Hematology, Medical College, Jinan University, Guangzhou, China.
3: Department of Hematology, Guangzhou First Municipal People's Hospital Affiliated to Guangzhou Medical College, Guangzhou, China.
4: Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, China.
5: Department of Hematology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
6: Institute of Hematology, Medical College, Jinan University, Guangzhou, China. yangqiuli@hotmail.com.
7: Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, China. yangqiuli@hotmail.com.
8: Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China. yangqiuli@hotmail.com.

Articles cited by this

The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol (1988) 5.10

Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol (2013) 4.72

Expanding antigen-specific regulatory networks to treat autoimmunity. Nature (2016) 3.10

Aplastic anemia. Curr Opin Hematol (2008) 2.17

Molecular cloning and chromosomal localization of the human T-cell receptor zeta chain: distinction from the molecular CD3 complex. Proc Natl Acad Sci U S A (1988) 1.95

Yin-Yang of costimulation: crucial controls of immune tolerance and function. Immunol Rev (2009) 1.39

Altered expression of the TCR signaling related genes CD3 and FcεRIγ in patients with aplastic anemia. J Hematol Oncol (2012) 1.23

CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic. Front Oncol (2015) 1.15

Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J Immunol (2004) 1.13

Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol (2015) 1.03

Nivolumab plus ipilimumab in the treatment of advanced melanoma. J Hematol Oncol (2015) 1.02

Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade. J Clin Invest (2015) 0.98

Polymorphisms/mutations of TCR-zeta-chain promoter and 3' untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3' untranslated region in patients with systemic lupus erythematosus. J Autoimmun (2001) 0.97

Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b. J Immunol (2005) 0.96

Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis Rheum (2004) 0.95

T cell immune abnormalities in immune thrombocytopenia. J Hematol Oncol (2014) 0.94

Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab. J Hematol Oncol (2015) 0.93

T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA. Arthritis Rheum (2001) 0.93

Advances in the management of gastrointestinal cancers--an upcoming role of immune checkpoint blockade. J Hematol Oncol (2015) 0.91

Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia. J Hematol Oncol (2015) 0.90

Understanding the CD28/CTLA-4 (CD152) pathway and its implications for costimulatory blockade. Am J Transplant (2014) 0.88

Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma. Hematology (2011) 0.88

T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol (2015) 0.86

The roles of stem cell memory T cells in hematological malignancies. J Hematol Oncol (2015) 0.85

Associations of CTLA4 Gene Polymorphisms with Graves' Ophthalmopathy: A Meta-Analysis. Int J Genomics (2014) 0.83

The +49A>G CTLA-4 polymorphism is associated with rheumatoid arthritis in Mexican population. Clin Chim Acta (2010) 0.83

A novel multiplex pyrosequencing assay for genotyping functionally relevant CTLA-4 polymorphisms: potential applications in autoimmunity and cancer. Hum Immunol (2014) 0.83

Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia. J Immunol (2016) 0.82

T Cell Receptor-induced Nuclear Factor κB (NF-κB) Signaling and Transcriptional Activation Are Regulated by STIM1- and Orai1-mediated Calcium Entry. J Biol Chem (2016) 0.81

Common variants on cytotoxic T lymphocyte antigen-4 polymorphisms contributes to type 1 diabetes susceptibility: evidence based on 58 studies. PLoS One (2014) 0.81

Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations. J Hematol Oncol (2014) 0.80

Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells? Front Immunol (2015) 0.80

The polymorphisms -318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic anemia in a Caucasian population. Bone Marrow Transplant (2005) 0.79

Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor. J Hematol Oncol (2015) 0.79

Upregulated TCRζ improves cytokine secretion in T cells from patients with AML. J Hematol Oncol (2015) 0.78

Highly efficient, in-vivo Fas-mediated apoptosis of B-cell lymphoma by hexameric CTLA4-FasL. J Hematol Oncol (2014) 0.78

Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. N Engl J Med (2015) 0.78

Individual MHCI-Restricted T-Cell Receptors are Characterized by a Unique Peptide Recognition Signature. Front Immunol (2013) 0.78

Identification of novel microRNA signatures linked to acquired aplastic anemia. Haematologica (2015) 0.78

Lead poisoning influences TCR-related gene expression patterns in peripheral blood T-lymphocytes of exposed workers. J Immunotoxicol (2014) 0.78

Abnormal quantity and function of regulatory T cells in peripheral blood of patients with severe aplastic anemia. Cell Immunol (2015) 0.77

Characteristics of TCRζ, ZAP-70, and FcɛRIγ gene expression in patients with T- and NK/T-cell lymphoma. DNA Cell Biol (2014) 0.77

TCR stimulation without co-stimulatory signals induces expression of "tolerogenic" genes in memory CD4 T cells but does not compromise cell proliferation. Mol Immunol (2014) 0.76